Figure 3
Structure of the β2-AR receptor in complex with the cocrystallized agonist P0G (8-[(1R)-2–1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one) and the docked peptide P3, prepared for the MD simulation.
Figure 3 | Scientific Reports
Structure of the β2-AR receptor in complex with the cocrystallized agonist P0G (8-[(1R)-2–1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one) and the docked peptide P3, prepared for the MD simulation.
